# A Study of Metronidazole Cream in the Prevention and Treatment of Tarceva (Erlotinib)-Associated Rash

> **NCT00642473** · PHASE2 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 34 (actual)

## Conditions studied

- Non-Squamous Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** Erlotinib
- **DRUG:** Metronidazole Actavis
- **OTHER:** Non-active Moisturizing Cream

## Key facts

- **NCT ID:** NCT00642473
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2016-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00642473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00642473, "A Study of Metronidazole Cream in the Prevention and Treatment of Tarceva (Erlotinib)-Associated Rash". Retrieved via AI Analytics 2026-09-25 from https://api.ai-analytics.org/clinical/NCT00642473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*